PIPELINE EMBOLIZATION DEVICE
Report
- Report Number
- 2029214-2014-00563
- Event Type
- Injury
- Date Received
- October 9, 2014
- Report Date
- September 9, 2014
- Manufacturer
- IRVINE
- Product Code
- OUT
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- SP
- Reporter Occupation
- OTHER
Narratives
THE DEVICE INVOLVED IN THE EVENT WILL NOT BE RETURNED FOR EVALUATION AS IT WAS IMPLANTED IN THE PATIENT. (B)(4).
UPDATING THE REPORT WITH THE MODELS OF THE PIPELINES INVOLVED IN THE EVENT. THE MODEL NUMBERS OF THE PIPELINES INVOLVED IN THE EVENT ARE AS FOLLOWS:MODEL#: FA-77275-14 / LOT#: NOT REPORTED / DOM: N/A / EXP N/A.MODEL#: FA-77275-18 / LOT#: NOT REPORTED / DOM: N/A / EXP N/A.(B)(4).
INFORMATION RECEIVED FROM MARTI-NEZ-GALDAMEZ M, ROMANCE A, VEGA P, ET AL. PIPELINE ENDOVASCULAR DEVICE FOR THE TREATMENT OF INTRACRANIAL ANEURYSMS AT THE LEVEL OF THE CIRCLE OF WILLIS AND BEYOND: MULTICENTER EXPERIENCE. J NEUROINTERVENT SURG. DOI: 10.1136/ NEURINTSURG-2014-011355. A TOTAL OF 25 PATIENTS (15 WOMEN AND 10 MEN) WITH ANTERIOR CIRCULATION ANEURYSMS WERE TREATED WITH A PIPELINE EMBOLIZATION DEVICE (PED) AT THE LEVEL OF THE CIRCLE OF WILLIS AND BEYOND. ALL PATIENTS WERE PRE-MEDICATED WITH DOUBLE ANTI-PLATELET THERAPY (ASPIRIN AND CLOPIDOGREL / ONE PATIENT RECEIVED TICAGRELOR). THE PEDS WERE DEPLOYED THROUGH A MARKSMAN MICROCATHETER USING A TRI-AXIAL GUIDE CATHETER SYSTEM IN ALL CASES. ALL DEVICES WERE PLACED PROPERLY, WITHOUT TECHNICAL DIFFICULTIES. THERE WERE NO ANEURYSM RUPTURES, PARENCHYMAL HEMORRHAGES, OR DEVICE MIGRATIONS DURING THE FOLLOW UP. CASE# 5: A PATIENT IN HIS/HER EARLY 60¿S WITH A SMALL RECANALIZED SACCULAR ANEURYSM (SAH 3 YEARS AGO) MEASURING 4MM LOCATED IN THE A1-A2 WAS TREATED WITH TWO PEDS (2.75MM X 14MM AND 2.75MM X 18MM) ON AN UNSPECIFIED DATE. A 24 HOUR CONTROL CT (COMPUTED TOMOGRAPHY) PRIOR TO DISCHARGE REVEALED A RIGHT ASYMPTOMATIC PARENCHYMAL HYPODENSITY IN THE HEUBNER¿S ARTERY TERRITORY. DSA (DIGITAL SUBTRACTION ANGIOGRAPHY) FOLLOW-UP REVEALED 70% ASYMPTOMATIC INTRASTENT STENOSIS. AT SIX MONTHS FOLLOW-UP, THE ANEURYSM WAS OCCLUDED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 635374 | PIPELINE EMBOLIZATION DEVICE | FLOW DIVERSION | OUT | IRVINE | PIPELINE | NOT REPORTED |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Disability |